Clinical Research

The retina specialists of Southeastern Retina Associates place a high priority on our commitment to the advancement of medical research. Our physicians continue to be in the forefront with their clinical research participation and in the development of major innovations in retina care.

Southeastern Retina Associates is proud of its participation in research studies demonstrating the highest professional standards and exemplary clinical practice. SERA physicians have been leading clinical trials for more than 15 years! Almost 500 SERA patients have taken part in the research trials. Patient participation in trials is voluntary, and has allowed the latest treatments to become available to all patients who need treatment for advanced eye diseases.

Southeastern Retina participates in several clinical trials that are investigating new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions.

Below, are descriptions of clinical trials in which we are currently participating or have recently participated at Southeastern Retina Associates’ three East Tennessee main locations. More information on clinical trials is available at clinicaltrials.gov.

 Current Clinical Trials

 

= currently enrolling = active or ongoing, but not enrolling

DRCR.net Diabetic Retinopathy Studies

Title

Description

Knoxville

Tri-Cities

Chattanooga

Protocol AA

Peripheral
Diabetic Retinopathy (DR) Lesions on Ultra wide-Field
Fundus Images and risk of DR worsening over time.

x

Protocol AB

Intravitreous
anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy

x

x

Protocol AC

Comparison
of anti-VEGF agents for Diabetic Macular Edema

x

Protocol AD

PROMINENT-Eye Ancillary Study (for those enrolled in the PROMINENT parent study)

x

x

Gene

Blood
sample collection and submission to the DRCR Genetic
Repository (open only to patients who are currently
enrolled in an applicable DRCR study).

x


x

Protocol TX

Anti-VEGF
Comparison for Diabetic Macular Edema – Follow-up
Extension Study

x


Protocol V

Treatment
for Central Diabetic Macular Edema in Eyes with “Very
Good Vision.”


x

Protocol W

Intravitreous
Anti-VEGF Treatment for Prevention of Vision-Threatening
Diabetic Retinopathy in Eyes at High Risk.

x

x

 

Diabetic Retinopathy | Diabetic Macular Edema

Title

Description

Knoxville

Tri-Cities

Chattanooga

PANORAMA

Study of
the Efficacy and Safety of Intravitreal (IVT) anti-VEGF
for the Improvement of Moderately Severe to Severe
Nonproliferative Diabetic Retinopathy. Sponsored by
Regeneron.


x

 

Retinal
Vein Occlusion

Title

Description

Knoxville

Tri-Cities

Chattanooga

SCORE2

Study of
Comparative Treatments for Retinal Vein Occlusion 2.
Sponsored by the National Eye Institute.

x

 

To ask about trials currently enrolling and the requirements to take part, patients or referring physicians may call any of SERA’s Clinical Trials Coordinators listed below.

Knoxville
Kristina Oliver or Steve Morris
865.588.0811

Chattanooga
Steve McBee  423.756.1002

Tri-Cities
Steve Morris 865.588.0811